Although CDH16 expression differences between renal cancer subtypes are statistically significant, our data do not suggest a relevant practical utility of CDH16 immunohistochemistry for subtype distinction at the selected experimental conditions. This evidence concerns the gene CDH16 and renal carcinoma.